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BACKGROUND: The effect of photodynamic therapy (PDT) on neural cells is important when tumours are within or adjacent to the
nervous system. The purpose of this study was to investigate PDT using the photosensitiser, meta-tetrahydroxyphenyl chlorin
(mTHPC), on rat neurons and satellite glia, compared with human adenocarcinoma cells (MCF-7).
METHODS: Fluorescence microscopy confirmed that mTHPC was incorporated into all three cell types. Sensitivity of cells exposed to
mTHPC-PDT (0–10mgml
–1) was determined in a novel 3-dimensional collagen gel culture system. Cell death was quantified using
propidium iodide and cell types were distinguished using immunocytochemistry. In some cases, neuron survival was confirmed by
measuring subsequent neurite growth in monolayer culture.
RESULTS: MCF-7s and satellite glia were significantly more sensitive to PDT than neurons. Importantly, 4mgml
–1mTHPC-PDT caused
no significant neuron death compared with untreated controls but was sufficient to elicit substantial cell death in the other cell types.
Initially, treatment reduced neurite length; neurons then extended neurites equivalent to those of untreated controls. The protocol
was validated using hypericin (0–3mgml
–1), which caused neuron death equivalent to other cell types.
CONCLUSION: Neurons in culture can survive mTHPC-PDT under conditions sufficient to kill tumour cells and other nervous
system cells.
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Photodynamic therapy (PDT) uses photosensitive drugs (photo-
sensitisers), combined with light and in the presence of molecular
oxygen to cause tissue destruction. A range of photosensitisers
have been developed, some of which have been used clinically for
cancer treatment. One such photosensitiser (meta-tetrahydroxy-
phenyl chlorin (mTHPC) Foscan, Biolitec AG, Jena, Germany) has
been reported to be effective in destroying tumour cells, although
not causing major damage to the peripheral nerves in experimental
models (Kubler et al, 2003) and in clinical practice (Ris et al, 1996;
Lou et al, 2004; Betz et al, 2007). It is not yet clear whether this
relative nerve sparing is a feature particular to mTHPC or shared
with other photosensitisers. Indeed, PDT using topical adminis-
tration of another photosensitiser, 5-aminolevulinic acid, is
associated with pain, perhaps through a direct interaction with
peripheral nerve endings in skin undergoing treatment (Stender
et al, 2006; Cottrell et al, 2008). A photosensitiser that enables PDT
to be used effectively to destroy tumours but spares nerve tissue
would be a valuable tool in the treatment of tumours whose
location makes nerve damage a likely side effect of traditional
surgical treatments. However, for this therapeutic benefit to be
fully exploited, the cell biology underlying the effects of mTHPC-
mediated PDT needs to be delineated.
There have been relatively few studies exploring the effects of
PDT on isolated cells of the peripheral nervous system. Most
studies of PDT on peripheral nervous system cells have used non-
mammalian models such as crayfish neurons, which provide a
useful system in which to compare photosensitisers, and monitor
their effects on neuronal function. Uzdensky et al showed that in
preparations of stretch receptors from crayfish, neuronal conduc-
tion was inhibited after PDT mediated by mTHPC at concentra-
tions as low as 10nM (with 633nm light at fluence rate 0.3Wcm
–2)
(Uzdensky et al, 2004). In separate studies with a different
photosensitiser the same group also attempted to explore the
effects of interactions between neurons and glia on PDT sensitivity
(Lobanov and Uzdensky, 2005).
Neuron–glia interaction is of fundamental importance when
investigating the effects of PDT on nerves. Peripheral nerves
comprise the axons of sensory and motor neurons, which are
accompanied by about ten times as many glial cells providing
metabolic and structural support (Hall, 2005). The glial cells along
the length of the peripheral nerves are termed Schwann cells and
those surrounding the neuronal cell bodies in the ganglia are
satellite cells (Jessen, 2004). Neurons and glia are intimately related
throughout the nervous system, and the level of complexity
surrounding their responses to each other means that, when
considering in vitro models, it is often more appropriate to use
cocultures of neurons and glia rather than try to study either cell
type in isolation.
In this study the aim was to investigate the effect of mTHPC-
mediated PDT on mammalian peripheral nerve cells. A novel cell
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sculture model was developed in which primary neurons and
satellite glia from dissociated rat dorsal root ganglia (DRGs)
were cocultured in collagen gels. Collagen gel systems have
been used previously to model peripheral nerves (Phillips et al,
2005) and have advantages over conventional monolayer cultures
for some investigations (Brown and Phillips, 2007). Here the
reason for using collagen gels was that they trap cells, which
die during PDT treatment, enabling accurate quantification of cell
death; this is in contrast to monolayer cultures, in which the
dead cells are more easily washed away, and can therefore be lost
for quantification purposes. Furthermore, relatively thin collagen
gels were used to facilitate illumination of cells during PDT
treatment and permit subsequent analysis of cell survival in
conjunction with immunofluorescence to distinguish neurons
from glia. Monolayer systems were also used where appropriate
for visualisation of photosensitiser uptake and quantification of
neurite length.
These model systems enabled accurate assessments to be made
of the sensitivity of neurons and glia to mTHPC-mediated PDT
using a well-established cancer cell line (MCF-7) as a comparator.
MATERIALS AND METHODS
Cell cultures
Neurons and satellite glial cells were cultured from DRGs, twenty
of which were isolated from each freshly culled 250–350g
Sprague–Dawley rat as previously described (Phillips et al,
2005). Using microscopic dissection, DRGs were removed, cleaned
of all nerve processes and incubated for 90min at 371Ci n
Dulbecco’s Modified Eagle’s Medium (DMEM) with L-glutamine
containing 0.125% collagenase (Sigma, St Louis, MO, USA), then
triturated to produce a cell suspension. Culture medium (DMEM
supplemented with 10% fetal calf serum (FCS) and 1% penicillin/
streptomycin) was added and cells were separated from the
collagenase by centrifugation for 5min at 100g and resuspended in
an appropriate volume of culture medium. Dorsal root ganglion
cells included both neurons and satellite glia. The tumour cells
used in this study were the human breast adenocarcinoma cell line,
MCF-7 (ECACC, Dorset, UK), used at passage 305–321.
MCF-7 cells were cultured in 75-cm
2 flasks in fully supplemen-
ted DMEM until 95% confluent whereupon they underwent routine
trypsinisation (0.25% trypsin–EDTA, 5min, 371C). Cells were
washed by centrifugation for 5min at 100g and resuspended in an
appropriate volume of culture medium.
Cell culture models
Two-dimensional (2D) and three-dimensional (3D) cell culture
models were used in this study. Photosensitiser uptake and neurite
length experiments were conducted using cells in 2D cultures,
whereas cell death assays used 3D cultures in order to trap non-
adherent cells that would have been lost from 2D cultures
following treatment.
For 2D cell culture, neural cells and MCF-7 cells were grown on
glass coverslips coated with 20mgml
–1poly-L-lysine (PLL, Sigma).
Cells were seeded in 100ml of suspension (1–2 10
5 cells per ml),
allowed to adhere for 30min, then incubated in 1ml culture
medium in 12-well culture plates.
For 3D cultures used for cell death assays, 5–7 10
5 DRG or
MCF-7 cells were suspended in 0.6ml culture medium, then added
to a solution containing 4.8ml type I rat tail collagen (2mgml
–1)
that had been mixed with 0.6ml 10  Minimal Essential Medium
and neutralised with 1 M NaOH. This mixture was then quickly
dispensed into 24-well plates, 200ml per well, and formed a gel
within 5min at 371C. Gels were covered with 1ml culture medium
and maintained in culture at 371C, 5% CO2, for 4 days (DRG cells)
or 1 day (MCF-7 cells) before experimentation. Pilot studies
showed no difference in response to mTHPC-PDT between MCF-7
cells cultured for 1 or 4 days (data not shown); the 1-day option
was chosen here to minimise time for proliferation of these rapidly
dividing cells.
Photodynamic therapy
Culture medium was removed from coverslips or gels and cultures
were incubated with photosensitiser drug. In all cases, mTHPC
(Biolitec AG) or hypericin (Tocris Cookson Ltd, Bristol, UK)
was added to the cultures in medium that contained
no phenol red indicator or FCS (colourless DMEM supplemented
with 1% penicillin/streptomycin and 1% L-glutamine), and plates
were incubated for 4h (mTHPC) or 7h (hypericin) in the dark at
371C, 5% CO2. The medium containing photosensitiser was then
removed, and the cultures were washed with phosphate-buffered
saline (PBS) before fresh colourless culture medium (supplemen-
ted with 10% FCS) was added, and the cultures were then exposed
to light. The drug incubation in colourless media and PBS washes
also served to remove any traces of phenol red indicator from the
collagen gels before light exposure.
For experiments investigating the effect of mTHPC on neurite
length in 2D neuronal cultures, blue light from a transilluminator
(LumiSource, PCI Biotech, Oslo, Norway) with a peak wavelength
of 420nm and a fluence rate of 7mWcm
–2 was used for 10min,
giving a total light dose of 4.2Jcm
–2. For cell death experiments on
cells in 3D cultures, white light from a transilluminator (Northern
Light Illuminator, InterFocus Imaging Ltd, Cambridge, UK) with a
fluence rate of 1.6mWcm
–2 was used for 10min, giving a total
light dose of 1Jcm
–2. The minimal thickness (o1mm), relatively
low cell density and transparent nature of the collagen gels ensured
that all cells within them received an equivalent light dose.
Controls were included in each experiment that involved excluding
either the drug (by using drug-free colourless medium during the
incubation step) or the light (by wrapping the plate in foil during
the illumination step) or both.
mTHPC detection within cells
To assess whether photosensitiser had been incorporated into cells,
the intrinsic fluorescence of mTHPC was detected using fluores-
cence microscopy. Cells were prepared as described and plated
onto coverslips in 2D culture, incubated with 4mgml
–1mTHPC for
4h, washed in PBS and fixed in 4% paraformaldehyde at 41Cf o r
1h. In some cases, cells were stained using immunocytochemistry
as described below. Meta-tetrahydroxyphenyl chlorin fluorescence
was detected using an Olympus BX61 fluorescence microscope
(excitation at 595nm, emission through long pass filter cut-on at
615nm) and images were captured using a ColorView Soft Imaging
System CCD camera and analySIS software (Olympus, Philadelphia,
PA, USA). Confocal microscopy was performed in some cases using
a Leica TCS-NT laser scanning microscope (Leica Microsystems,
Wetzlar, Germany). In specific cases cells were labelled immuno-
cytochemically as described below.
Immunostaining
Immunostaining was carried out to distinguish neurons from
satellite glial cells in the DRG cultures after PDT treatment.
Neurons were detected using an antibody to b-III-tubulin, and
satellite glia were detected using an antibody to S100 (Phillips et al,
2005). All dilutions and washes were carried out using PBS.
Coverslips and gels were washed, then fixed in 4% paraformalde-
hyde for 1h at 41C, washed again, then permeabilised using 0.5%
Triton-X-100 for 10min, then washed and blocked with 5% swine
serum (DAKO, Glostrup, Denmark) for 10min. After washing,
cells were incubated for 1.5h in primary antibody, either mouse
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DAKO) or both, washed, then incubated for 45min in the appro-
priate anti-species secondary antibody (1:100, Sigma) conjugated
to fluorescein isothiocyanate or tetramethylrhodamino isothio-
cyanate (TRITC) before final washing and mounting. Nuclei were
stained using 10mM Hoechst 33258 (Sigma), which was included in
the secondary antibody incubation.
Effect of PDT on neurite length
For investigating the effect of PDT on neurite length in 2D culture,
cells obtained from the DRGs of one rat were resuspended in 2.5ml
culture medium, then 100ml of this cell suspension was seeded
onto 19mm diameter glass coverslips and incubated in culture
medium at 371C in a 5% CO2 humidified atmosphere for 3 days
before drug treatment.
To assess the ability of neurons to produce neurites after they
had been subjected to PDT in 3D collagen gels, neurons were
extracted from collagen at 24h after PDT treatment by incubation
with 0.125% collagenase for 30min, which released the cells into
suspension. Cells were then collected by centrifugation at 100g,
washed in culture medium, then mixed with a suspension of
satellite glial cells, seeded onto PLL-coated 19-mm diameter
coverslips and maintained in culture for 2 days before fixation
and immunostaining. The satellite glial cells used for this stage
were previously obtained from DRGs as described, but were
expanded in PLL-coated flasks until confluent, then subjected to
cycles of trypsinisation, transferred to new flasks, then further
expanded to dilute the neuronal population (the neurons are
postmitotic). During each cycle, confluent cultures were subjected
to vigorous shaking to dislodge neurons, which were then
discarded. The resulting satellite glial cultures contained no
detectable neurons, as determined by immunostaining for b-III-
tubulin in control samples (data not shown).
Neurite length measurement
b-III-tubulin immunoreactivity was detected in DRG cultures on
coverslips using a fluorescence microscope (Nikon Diaphot, Nikon,
Tokyo, Japan) or Olympus BX61 (Olympus), and images were
captured using a CCD camera (Hamamatsu Orca, Hamamatsu
Photonics, Hamamatsu, Japan) or ColorView Soft Imaging System
and Openlab (Improvision, Coventry, UK) or analySIS software.
Total neurite length was measured on each coverslip by manually
tracing all of the detectable neuronal processes and summing their
lengths. For the investigation of neurite growth after PDT in 3D gels,
one coverslip containing neurons from half a gel mixed with
1.2 10
4 untreated satellite cells was used, all the neurons on each
coverslip were assessed for the presence or absence of neurites, and
the total neurite length was measured as before.
Cell death analysis
Propidium iodide was used to determine the extent of cell death at
24h after PDT in 3D cell cultures. Collagen gels were incubated
with 200mgml
–1propidium iodide in PBS for 10min, then washed
in PBS and fixed using 4% paraformaldehyde overnight. Gels were
then immunostained to distinguish between neurons and glia as
described above and analysed using fluorescence microscopy
(Olympus BX61). In this way, dead cells could be distinguished
from those that were alive before fixation by the presence of
propidium iodide in their nuclei. The numbers of live and dead
satellite glia and MCF-7 cells were determined by manually
counting and scoring all cells in three 3D fields of each gel
(typically a total of B160 cells per gel). Fields were chosen at
random using a  40 objective, and the operator performing the
counting was blinded as to which treatment each of the gels had
received. The operator focussed through all planes of the gel
during the counting process so that each field was a cylindrical
sample through the gel from top to bottom. Pilot experiments
confirmed that sampling three fields in this way was sufficient to
provide an accurate representation of the whole gel. There were
considerably fewer neurons than satellite glia in each gel, hence all
of the b-III-tubulin immunoreactive cells in each gel (typically
up to 50 neurons) were identified and classified as being live or
dead. For statistical analyses, live/dead cell counts from the three
pooled 3D fields (MCF-7s and satellite glia) or all the neurons
in each of the nine independent gels (mTHPC) or six inde-
pendent gels (hypericin) were analysed using one-way analysis of
variance (ANOVA) with Tukey’s post-hoc test to compare groups.
Data were displayed as mean % cell death to normalise differences
in absolute cell number between experiments. Basal levels of
cell death with and without light exposure are listed in the figure
legends.
RESULTS
Detection of mTHPC
mTHPC was detected in the cytoplasm of all cells The presence of
mTHPC in neurons, satellite glia and MCF-7 cells was detected
using fluorescence microscopy of 2D cultures (Figure 1A). mTHPC
fluorescence was detected throughout the cytoplasm in each cell
type but was not present in the nuclei or in the neurites (the axonal
projections of neurons). Confocal microscopy was performed on
DRG cultures to confirm the results of the fluorescence micro-
scopy. Figure 1B shows neurites bridging areas of satellite glia, and
although there is drug fluorescence in the cell bodies of the neuron
and glia, none is detectable along the neurites.
Effect of PDT on neurite length
mTHPC-mediated PDT reduced the length of neurites in 2D
culture The effect of mTHPC-mediated PDT on neurite length in
DRG cultures was tested in the 2D system. After 3 days in culture,
cells were treated with mTHPC and light, and the effect of this
treatment on neurite length was analysed 24h later (Figure 2 and
Supplementary Figure 2). There was no statistically significant
effect on the neurite length when drug or light were applied
separately, or when PDT was performed using 0.1mgml
–1mTHPC,
whereas PDT using higher concentrations of mTHPC (0.3mgml
–1
and above) caused a significant reduction in neurite length
compared with untreated controls (Po0.001, one-way ANOVA
with Dunnett’s post test).
Relative sensitivity of different cell types to mTHPC-PDT
Neurons showed lower sensitivity to mTHPC-mediated PDT than
MCF-7s and glia The extent to which mTHPC-mediated PDT
caused cell death was explored in neurons, satellite glia and MCF-
7s using a 3D culture system. The dose-response profile obtained
showed a difference in sensitivity between the cell types, with
neurons showing considerably less sensitivity to mTHPC-mediated
PDT than the other cell types (Figure 3). In particular, at
concentrations of 4mgml
–1,4 8 ±5.4% of MCF-7 cells and
39±4.0% of satellite glia died compared with only 11.9±1.4% of
neurons (Po0.001 using one-way ANOVA with Tukey’s post test),
which showed no more death than their untreated counterparts.
It is worth noting that the neuronal death that was detected was
not significantly different from the amount detected in drug-only
(no light) controls (Figure 3B) at concentrations up to and
including 10mgml
–1mTHPC (one-way ANOVA with Tukey’s post
test), nor was it significantly different from that detected after light
treatment in 0mgml
–1 mTHPC controls.
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Figure 1 Representative micrographs showing (A) mTHPC fluorescence within the cell body of neurons (i and ii), satellite glia (iii) and MCF-7 cells (iv),
but not detected in neurites (v). (B) Confocal micrograph projections confirming the presence of mTHPC fluorescence in neuronal cell body and satellite
glia, but none detectable along the neurite. Meta-tetrahydroxyphenyl chlorin fluorescence is shown in red, b-III-tubulin immunoreactivity is shown in green,
nuclei are blue. All scale bars are 20mm. Confocal images are maximum intensity projections from 40 optical sections in a 14mm z-series.
Nerve PDT
KE Wright et al
661
British Journal of Cancer (2009) 101(4), 658–665 & 2009 Cancer Research UK
T
r
a
n
s
l
a
t
i
o
n
a
l
T
h
e
r
a
p
e
u
t
i
c
sNo change in neural cell death at different times after PDT In
Figure 3, the extent of cell death at 24h after PDT was used to show
the differences in sensitivity between neurons and other cells. The
time course for cell death after PDT can vary according to cell type,
drug/light dose and various other parameters, so it was important
to establish that the 24h time point was appropriate for this study.
Therefore, parallel cultures of neurons and satellite glia were
treated using 4mgml
–1 mTHPC and maintained in culture up to
36h. Figure 4 shows the time course of cell death after mTHPC-
mediated PDT. There was no significant difference in the extent of
cell death in the cultures analysed after different lengths of time.
Relative sensitivity of different cell types to hypericin-PDT
Neurons, MCF-7s and glia were all sensitive to hypericin-mediated
PDT To investigate the sensitivity of the cells to another PDT
agent and confirm that neuronal death could be detected using this
model, the experiment was repeated using hypericin. As for
mTHPC, hypericin fluorescence was detected throughout the
cytoplasm in each cell type, but was not present in the nuclei or
in the neurites (Supplementary Figure 1). Figure 5 shows that
hypericin-mediated PDT resulted in neuronal death, following a
similar dose-response pattern to that of satellite glia and MCF-7
cells, and at concentrations of 2.2mgml
–1 and above, there was a
significant difference in cell death between hypericin-PDT-treated
neurons and untreated controls (Po0.001 using one-way ANOVA
with Tukey’s post test).
Functionality of neurons after mTHPC-PDT
Spared neurons were functional after mTHPC-mediated
PDT Having established that PDT with 3, 4 and 10mgml
–1
mTHPC resulted in a low level of neuronal death in the 3D culture
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Figure 2 Reduction in neurite length due to mTHPC-mediated PDT.
Dorsal root ganglion neurons were cultured on coverslips for 3 days, then
treated with various concentrations of mTHPC and light, then maintained
in culture for a further 24h before fixation and quantification of the total
length of all b-III-tubulin immunoreactive neurites. Data are means±s.e.m.,
N¼4. (**Po0.001 for treatments compared with no drug or light control,
one-way ANOVA with Dunnett’s multiple comparison post test).
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Figure 3 Relative sensitivity of cells to mTHPC-mediated PDT. Cell
death (neurons, satellite glia and MCF-7 cells) in the presence of various
concentrations of mTHPC after light exposure (A) or in control samples
with no light exposure (B). Differences in cell death in neurons compared
with MCF-7 cells and satellite glia were present at concentrations above
2mgml
–1mTHPC, with B50% cell death for MCF-7 cells and satellite glia
at 4mgml
–1. Neuronal cell death after this treatment was significantly lower
at B12%, which was not different from untreated neurons (Po0.001 using
one-way ANOVA with Tukey’s post test). Data are means±s.e.m. of at
least nine replicates. Basal levels of % cell death using 0mgml
–1 mTHPC
with light were 3.7±0.8, 4.3±1.3 and 7.6±1.0, and with no light were
3.1±1.0, 4.2±1.4 and 1.89±0.7, for neurons, satellite glia and MCF-7s,
respectively.
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Nerve PDT
KE Wright et al
662
British Journal of Cancer (2009) 101(4), 658–665 & 2009 Cancer Research UK
T
r
a
n
s
l
a
t
i
o
n
a
l
T
h
e
r
a
p
e
u
t
i
c
ssystem, the ability of ‘spared’ neurons to sprout neurites was
investigated. After PDT, neurons (along with remaining glia and
dead cells) were harvested from collagen gels using enzymatic
digestion, mixed with untreated satellite glia, then seeded in a
monolayer culture. Figure 6A shows the numbers of b-III-tubulin
immunoreactive neuronal cell bodies that showed neurite growth
at 2 days after transfer to monolayer culture. Similar numbers of
neurons were detected in control, light only and 3 and 4mgml
–1
mTHPC-mediated PDT samples, although there were approxi-
mately one-third as many neurons detected in the 10mgml
–1
mTHPC-mediated PDT sample. There were similar numbers of
neurons without neurite growth in all groups. Overall, it is
apparent that neurons treated with 3 and 4mgml
–1 mTHPC-
mediated PDT showed no difference to untreated and light-only
controls in their ability to produce neurites.
Furthermore, when the length of neurite growth was quan-
tified (Figure 6B and Supplementary Figure 3), there was no
significant difference in the extent of neurite outgrowth between
the control and light only, and 3 and 4mgml
–1 mTHPC-mediated
PDT-treated cells, with only the 10mgml
–1 mTHPC-mediated
PDT-treated cells showing significantly reduced neurite out-
growth compared with light-only control (one-way ANOVA with
Dunnett’s post test).
DISCUSSION
The key finding from this study is that DRG neurons were
less sensitive to mTHPC-mediated PDT than their associated
satellite glial cells and the tumour cell line, MCF-7, both of
which exhibited dose-dependent cell death over the range of
treatment concentrations used here. Importantly, photosensitiser
concentrations of 3–4mgml
–1 mTHPC caused no dark toxicity
but, when activated by light, yielded substantial glial and
MCF-7 cell death as previously reported for MCF-7 cells in other
culture systems (Koechli et al, 1995). At these concentrations,
there was no detectable neuronal death above that seen in
untreated controls. This is an important observation as it
indicates that DRG neurons are able to survive PDT treatments
that kill tumour cells, offering the possibility that therapeutic
regimens could be developed to treat tumours in close proximity
to neurons.
However, it is clear from this study that PDT using lower
doses of mTHPC (0.3mgml
–1) can have a profound effect on
DRG neurons growing in 2D cell culture, causing a substantial
reduction in neurite length. This effect is reversible, however,
since when neurons treated with 3 and 4mgml
–1 mTHPC-
mediated PDT were cocultured with untreated glial cells, they
exhibited the same level of neurite extension as untreated neurons.
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Figure 6 Neurons survive mTHPC-mediated PDT and produce new
neurite outgrowth. After treatment with mTHPC-mediated PDT in 3D
culture, neurons were grown in 2D in the presence of untreated satellite
glia for 2 days. A similar number of neuronal cell bodies had neurites
associated with them in the 3–4mgml
–1mTHPC-mediated PDT samples
as in the controls (A). There was a similar level of neurite length detected
in controls and treated neurons, except for the samples that had received
10mgml
–1mTHPC-mediated PDT, which showed a significant reduction in
neurite length (*Po0.05) (B).
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as an important indication that they remain functionally active
following survival of PDT treatment in terms of their regenerative
capacity.
It should be noted that previous studies showed that PDT
using mTHPC was sufficient to inhibit conduction in crayfish
stretch receptor neurons at concentrations much lower than
those used in this study (10nM, equivalent to 0.0068mgml
–1)
(Uzdensky et al, 2004). These previous data, together with our
neurite retraction results, indicate that, in cell culture, neuronal
function is compromised by mTHPC-mediated PDT, but that
unlike other cell types they have the capacity to survive PDT
treatment with the potential for regeneration and subsequent
restoration of function. It is interesting that the decrease in
neurite length in 2D cultures occurs despite the lack of detection of
any photosensitiser along the length of the neurites. It is possible
that mTHPC was present in this narrow cellular region that
could not be detected because of limitations in the resolution
of the microscopy. This would be consistent with the lack of
detection of the control photosensitiser hypericin in neurites
under the same conditions. Alternatively, it could be that
activation of mTHPC localised to the neural cell body is sufficient
to cause a reduction in neurite length. Detailed investigation of the
cellular localisation of mTHPC within neurons would be a useful
future direction as differences in drug distribution between
neurons and other cells might account for the differences in
sensitivity reported here.
The accurate detection of the effects of mTHPC-mediated PDT
on mammalian cell death in this study was made possible by the
development of a bespoke culture system. This used a thin collagen
gel as a support substrate for the cells under investigation,
enabling a powerful combination of cell death analysis and cell
identification to be carried out. Collagen gels have been used as
culture substrates for many years because they provide a 3D
environment in which cells can grow in a more natural spatial and
physical environment than they would on a stiff monolayer
substrate (Kim et al, 2004; Brown and Phillips, 2007). The rate of
diffusion of oxygen and other nutrients through collagen gels is
relatively rapid, facilitating cell survival under normal conditions
and ensuring that oxygen availability does not become a limiting
factor during PDT treatment. However, the main advantage of
using a collagen gel system in this study was that cells remained
trapped within the gels throughout treatment and in subsequent
analysis stages. This meant that cell death could be determined
accurately – in many studies in which conventional cell mono-
layers are used, a proportion of cells (particularly dead ones) are
washed away during these stages, so the resulting analyses of cell
death or cell viability (for example, live/dead staining, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide (MTT)
assay) do not account for all of the cells. Furthermore, trapping
the cells in this manner enabled the multiple washes and
incubations required for a propidium iodide assay to be used in
conjunction with an immunostaining technique so that numbers of
live or dead neurons and glial cells could be analysed separately
within a coculture.
As the interaction between neurons and their associated glial
cells is important for neuronal function and survival, coculture
systems such as this are often favoured over isolated neuronal
cultures. This is the first study in which the differential effects of
mTHPC-mediated PDT have been shown on mammalian DRG
neurons and glia in coculture. A previous study using isolated
crayfish stretch receptors (neurons and glia) and the photosensi-
tiser Photosens (a mixture of sulphonated alumophthalocyanines)
mentioned that glial cells seemed more sensitive than neurons to
proteolytic and PDT treatments in that system (Lobanov and
Uzdensky, 2005). It would be interesting to explore whether
mammalian neurons and glia have different sensitivities to
Photosens in our system. The complex relationship between
neurons and glia makes it difficult to speculate about a mechanism
by which PDT reduced neurite length without killing neurons, as
neurite outgrowth can be influenced by factors such as the level of
activation of the supporting glia (Armstrong et al, 2008),
membrane proteins expressed on the surface of the glia (Castro
and Kuffler, 2006) and diffusible factors released from them
(Armstrong et al, 2007). This means that the changes in neurite
length measured in these cocultures could be a result of the
effect of the PDT on the accompanying glia rather than a direct
effect on the neurons. Therefore, it was important to culture the
treated neurons with untreated glial cells in the experiments to
determine the functionality of neurons after PDT, thus removing
the influence the PDT-treated glia might exert on neurite growth.
Remarkably, the neurons, which had been treated with PDT using
3–4mgml
–1 mTHPC, not only produced neurites, they did it in a
manner indistinguishable from untreated and light-only treated
controls, both in terms of the proportion of neuronal cell bodies
detected that showed neurite outgrowth and in terms of their
length. Neurite outgrowth is a well-established measure of
neuronal behaviour in cell culture models using DRGs; so, this
acts as a compelling indication that the neuronal survival detected
in the cell death assays was genuine and that neurons survived the
mTHPC-mediated PDT doses administered in this system.
In this study, hypericin was used as an alternative to mTHPC
primarily to validate the culture system. The sensitivity of MCF-7
cells to hypericin-mediated PDT in this system was similar to that
previously reported (Vandenbogaerde et al, 1997). The high level
of neuronal death (B90%) detected after hypericin-mediated PDT
showed that the lack of neuronal cell death after mTHPC-mediated
PDT was not due to an inability to detect neuronal death in this
system. Together, the mTHPC and hypericin data show that this
system can be used to compare mixtures of cells in coculture,
exposing them to PDT and then combining cell death analysis with
immunofluorescence identification to dissect out any differences
in sensitivity between the cell populations. This is a valuable
model which could facilitate research in which the response of
two or more cell types to PDT needs to be evaluated and may
be particularly useful for studies comparing responses in tumour
cells and non-tumour cells during screening for selective photo-
sensitisers.
The results presented here indicate that there are particular
mTHPC-mediated PDT conditions in which neurons survive
treatments that kill tumour cells and glia. This observation needs
to be followed up by animal studies to explore whether this
phenomenon occurs in vivo before its potential for application in
the clinical setting can be determined. Importantly, in the animal
studies and human cases in which peripheral nerve sparing
has been reported, the PDT was applied to the nerve trunk rather
than to the ganglia containing the neuronal cell bodies (Ris et al,
1996; Kubler et al, 2003; Lou et al, 2004; Betz et al, 2007).
Our in vitro study indicates that neurons might survive PDT
directly applied to the ganglia if an appropriate mTHPC
concentration and light dose were used, enabling PDT to be
applied to areas of the body rich in neuronal cell bodies such as the
DRGs without killing the neurons. An important consideration for
the further investigation of neuronal sparing during PDT is the
role of the vasculature. Nerve tissue is highly vascularised and its
function is dependent on effective perfusion (Myers et al, 1986;
Hogan, 2008). This feature of nerve tissue is not accounted
for in cell culture and in vivo if neurons survived a PDT insult they
might still be compromised by severe damage to their blood
supply. It has been shown in rabbits that some blood vessels are
relatively resistant to mTHPC-mediated PDT (Kubler et al, 2003),
however, in studies investigating the effect of other photosensi-
tisers, it has been difficult to determine whether nerve function is
affected by direct damage to neurons or indirect damage to the
vasculature supplying the neural tissue (Dole et al, 2005; Huang
et al, 2007).
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showed relative nerve sparing would be particularly helpful in the
prostate, where nerve damage during treatment for prostate cancer
is related to loss of erectile function, and in cancers of the head and
neck, which can lie in close proximity to nerves of great functional
importance, and in the treatment of bone metastases in the spine,
which can lead to effects on adjacent nerves. The model described
here could allow the further pre-clinical investigation of different
photosensitisers, which are being considered for clinical use in
these areas.
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